When was RVL Pharmaceuticals plc stock made available for the first time to the public?

The IPO Date for RVL Pharmaceuticals plc is 2018-10-19. On this 2018-10-19, RVL Pharmaceuticals plc stock was made publicly available.

Where is the headquarters of RVL Pharmaceuticals plc stock?

Headquarters of RVL Pharmaceuticals plc is in US at 400 Crossing Boulevard, Bridgewater, NJ 08807.

What industry does RVL Pharmaceuticals plc belong to?

The RVL Pharmaceuticals plc belongs to Biotechnology.

RVL Pharmaceuticals plc

RVLP•NASDAQ

Healthcare

Biotechnology

$0.03

$-0.01(-32.05%)

RVL Pharmaceuticals plc (RVLP) Company Profile & Overview

Explore RVL Pharmaceuticals plc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

RVL Pharmaceuticals plc (RVLP) Company Profile & Overview

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

SectorHealthcare

IndustryBiotechnology

CEOBrian A. Markison

Contact Information

https://www.rvlpharma.com

908 809 1300

400 Crossing Boulevard, Bridgewater, NJ, 08807

Company Facts

125 Employees

IPO DateOct 19, 2018

CountryUS

Frequently Asked Questions

;